![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1629200
Àڱ󻸷 ÀýÁ¦ ½ÃÀå : À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - ¼¼°è »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)Endometrial Ablation Market, By Type, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
Àڱ󻸷 ÀýÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 3¾ï 9,860¸¸ ´Þ·¯·Î 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 5.80%ÀÇ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àڱ󻸷 ÀýÁ¦ ½ÃÀå - ½ÃÀå ¿ªÇÐ
ºñÁ¤»ó Àڱà ÃâÇ÷(AUB)ÀÇ Áõ°¡
ºñÁ¤»ó Àڱà ÃâÇ÷(AUB)ÀÇ Áõ°¡´Â Àü ¼¼°è Àڱ󻸷 ÀýÁ¦ ½ÃÀåÀÇ ÁÖ¿ä µ¿ÀÎÀÔ´Ï´Ù. ¿ù°æ°ú´ÙÁõÀº ¿©¼ºÀÇ »îÀÇ ÁúÀ» ½É°¢ÇÏ°Ô ÀúÇϽÃų ¼ö ÀÖ´Â ÁúȯÀ¸·Î, ºÒ±ÔÄ¢Çϰųª ±Øµµ·Î ½ÉÇÑ ¿ù°æÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¿©±â¿¡´Â ƯÈ÷ ÃâÇ÷ÀÌ ½ÉÇϰųª Àå±â°£ Áö¼ÓµÇ´Â ¿ù°æ°ú´Ù, »ý¸® ÁßÀ̳ª »ý¸® »çÀÌ¿¡ ÃâÇ÷ÀÌ °ú´ÙÇÑ ¿ù°æ°ú´Ù, »ý¸® »çÀÌ¿¡ ÃâÇ÷ÀÌ ÀÖ´Â ¿ù°æ°ú´Ù µîÀÌ Æ÷ÇԵ˴ϴÙ. ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¿ù°æ°ú´ÙÁõ »ç·Ê°¡ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ¹ßÀüÇÏ°í ´õ ¸¹Àº Áø´Ü°ú Ä¡·á¹ýÀÌ Á¦°øµÊ¿¡ µû¶ó ÀÇÇÐÀû Á¶¾ðÀ» ±¸ÇÏ°í »ý¸® °Ç° ¹®Á¦¿¡ ´ëÇØ ´õ Àß ¾Ë°Ô µÈ ¿©¼ºÀÌ Áõ°¡ÇÏ´Â µ¥ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª´Â »ý¸® °ï¶õ¿¡ ´ëÇÑ Àνİú ½Äº°·ÂÀÌ ³ô¾ÆÁ³´Ù´Â °ÍÀÔ´Ï´Ù. ½ºÆ®·¹½º, ºñ¸¸, »ý½Ä °Ç° ÇൿÀÇ º¯È¿Í °°Àº »ýȰ ½À°ü º¯Èµµ ¿ù°æ°ï¶õÁõ ¹ßº´·ü Áõ°¡¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù.
¶ÇÇÑ, °í·Éȵµ AUB À¯º´·ü Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. °í·É ¿©¼ºÀº È£¸£¸ó ÀÌ»óÀ¸·Î ÀÎÇØ »ý¸®ºÒ¼øÀÇ ºóµµ°¡ Áõ°¡ÇÕ´Ï´Ù. ÀÌ´Â AUB Áõ»óÀ» º¸ÀÌ´Â ¿©¼ºÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» ½Ã»çÇÕ´Ï´Ù.
Àڱ󻸷 ÀýÁ¦ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¿¬±¸ ºÐ¼®°¡µéÀÌ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 5.80%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
À¯Çü ¼¼ºÐȸ¦ ±â¹ÝÀ¸·Î, ÀåÄ¡´Â 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.
ÃÖÁ¾ »ç¿ë ¼¼ºÐÈ¿¡ µû¶ó 2024³â º´¿øÀÌ ÁÖ¿ä ºÎ¹®À¸·Î ºÎ»óÇß½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â¿¡ ¼öÀÍÀ» âÃâÇÏ´Â ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇß½À´Ï´Ù.
Àڱ󻸷 ÀýÁ¦ ¼¼°è ½ÃÀåÀº À¯Çü, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
À¯Çüº°·Î ½ÃÀåÀº ÀåÄ¡(¸¶ÀÌÅ©·ÎÆÄ ¿¡³ÊÁö, °íÁÖÆÄ ÀýÁ¦¼ú, ¿Ç³¼±, ±ØÀú¿Â ÀýÁ¦¼ú, ¼ö¿ ÀýÁ¦¼ú, Àڱðæ)¿Í ½Ã¼ú·Î ±¸ºÐµÇ¸ç, 2024³â¿¡´Â ÀåÄ¡ ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. dz¼± ³»¿¡ °¡¿µÈ À¯Ã¼¸¦ ÁÖÀÔÇÏ¿© Àڱ󻸷À» ÆÄ¼âÇϴ dz¼±¿ä¹ý, °í¿¡³ÊÁö ÀüÆÄ¸¦ ÀÌ¿ëÇÏ¿© Àڱ󻸷 Á¶Á÷À» ÆÄ±«ÇÏ´Â °íÁÖÆÄ ¼ÒÀÛ¿ä¹ý, ±ØÀú¿Â À¯Ã¼³ª Å©¶óÀÌ¿ÀÇÁ·Îºê¶ó´Â ±â±¸¸¦ ÀÌ¿ëÇÏ¿© ÀÌ»óÁ¶Á÷À» µ¿°á ¹× ÆÄ¼âÇÏ´Â ¹æ¹ý µî È¿À²ÀûÀÎ ¹æ¹ý ¹× µµ±¸°¡ ´Ù¼ö µîÀåÇß½À´Ï´Ù. ´Ù¾çÇÑ ¹æ¹ý ¹× µµ±¸°¡ °¡´ÉÇØÁ³±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÎ¹®ÀÇ ¼ö¿ä´Â Ãß°¡ Àڱ󻸷 Á¦°Å ÀåÄ¡¿Í ºñ±³ÇÏ¿© È¿°ú, Á¦Ç° ÆíÀǼº, ºü¸¥ Ä¡·á, Àú·ÅÇÑ °¡°Ý µîÀÇ ÀåÁ¡¿¡ ±âÀÎÇÏ´Â ¹Ù°¡ Å®´Ï´Ù. ¶ÇÇÑ, Àǻ簡 Àڱ󻸷 Á¦°Å ÀåÄ¡¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ °¡±î¿î ¹Ì·¡¿¡ ÀÌ ½ÃÀå ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC), ±âŸ·Î ±¸ºÐµÇ¸ç, 2024³â¿¡´Â º´¿ø ºÎ¹®ÀÌ ¾ÐµµÀûÀÎ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Á߿伺Àº ºÎÀΰú ÁúȯÀ¸·Î ÀÎÇÑ ÀÔ¿ø ȯÀÚ Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç, º´¿øÀÇ ¼÷·ÃµÈ Ä¡·á¿Í À¯¸®ÇÑ º¸»ó °üÇàÀÌ À̸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. º´¿øÀº ÃÖ÷´Ü Ä¡·á ±â¼úÀ» º¸À¯Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú Áß ¹ß»ýÇÒ ¼ö ÀÖ´Â ÇÕº´Áõ¿¡ ´ëÇÑ Ã¶ÀúÇÑ ´ëÀÀ°ú º´¿ø ³»¿¡¼ ´Ù¾çÇÑ Ä¡·á ¿É¼ÇÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ´Ù´Â Á¡µµ ´Ù¸¥ ÀÇ·á ȯ°æ°ú ºñ±³ÇÏ¿© ȯÀÚ ¼ö Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Àڱ󻸷 ÀýÁ¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®
2024³â ºÏ¹Ì´Â Àڱ󻸷 ÀýÁ¦ ¼¼°è ½ÃÀå¿¡¼ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§´Â ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ÇöÀúÇÑ °³¼±, ÃÖ÷´Ü Àڱ󻸷 ÀýÁ¦ Àåºñ¸¦ °ø±ÞÇÒ ¼ö ÀÖ´Â ÁÖ¿ä »ê¾÷ ±â¾÷ÀÇ Á¸Àç¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼´Â ȯÀÚ °á°ú¿Í ¾ÈÀü¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÁýÁßÀ» ÅëÇØ ÀÇ·áÀÇ Áú Çâ»ó°ú ºñ¿ë Àý°¨¿¡ ´ëÇÑ ³ë·ÂÀÌ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀÇ·áºñ ÁöÃâÀº Àü ¼¼°è ´Ù¸¥ Áö¿ªº¸´Ù ³ôÀ¸¸ç, ÀÌ´Â ½ÃÀå »ó½Â¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÇâÈÄ ¸î ³â µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àڱ󻸷 ÀýÁ¦ ½ÃÀå¿¡¼ °¡Àå Å« CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÒÃæºÐÇÑ Ã»°á ½À°üÀ¸·Î ÀÎÇÑ »ý¸®Åë ¹ß»ý·üÀÇ Áõ°¡¿Í ÷´Ü ¹× Á¤±³ÇÑ Àڱ󻸷 ÀýÁ¦ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯¸®ÇÑ Á¤ºÎ ±ÔÁ¦, ÇコÄÉ¾î »ê¾÷¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ºÎÁ¤ Àڱà ÃâÇ÷¿¡ ´ëÇÑ ÀÎ½Ä È®´ë, ÃÖ¼Òħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ë¼º Áõ°¡·Î ÀÎÇØ ÀÌ ºÎ¹®Àº ÇâÈÄ ¸î ³â µ¿¾È ¼öÀÍÀ» âÃâÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àڱ󻸷 ÀýÁ¦ ½ÃÀåÀº °æÀïÀÌ Ä¡¿Çϸç, ¸¹Àº ÁÖ¿ä ±â¾÷µéÀÌ ºÎÀΰú Áúȯ¿¡ ´ëÇÑ µ¶Ã¢ÀûÀÌ°í ½Ç¿ëÀûÀÎ Ä¡·á¹ýÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀå Á¡À¯À²À» È®º¸Çϱâ À§ÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. Smith &Nephew Plc,Johnson & Johnson,Hologic,Olympus Corporation,The Cooper Companies, Inc. Karl Storz GmbH &Co.KG µîÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù. ÀÌ ±â¾÷µéÀº ÆÄÆ®³Ê½Ê, Àμö, ÇÕº´, Á¦ÈÞ µîÀÇ Àü¼úÀ» »ç¿ëÇÏ¿© Á¦Ç° ¶óÀÎÀ» È®ÀåÇÏ°í ±¹Á¦ÀûÀÎ ¹ßÀÚÃ븦 °ÈÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù Olympus CorporationÀº »õ·Î¿î Àڱ󻸷 ÀýÁ¦ µµ±¸ ÀÎ EnSeal Endometrial Ablation SystemÀ» ¹ßÇ¥Çß½À´Ï´Ù. EnSeal Endometrial Ablation SystemÀ̶ó°í ºÒ¸®´Â ¾ç±Ø¼º °íÁÖÆÄ ¼ÒÀÛ µµ±¸´Â HMBÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù.
ÃÖ±Ù µ¿Çâ
2023³â 2¿ù, Hologic Inc.ÀÇ NovaSure V5 ¼¼°è Àڱ󻸷 ÀýÁ¦(GEA)ÀÌ Ä³³ª´Ù¿Í À¯·´ ½ÃÀå¿¡¼ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ ¾à¹°Àº Àڱ󻸷 ÀÌ»ó ÃâÇ÷(AUB) Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù.
2023³â 1¿ù, HologicÀº »õ·Î¿î Àڱ󻸷 ÀýÁ¦ ÀåÄ¡ÀÎ NovaSure¸¦ Ãâ½ÃÇß½À´Ï´Ù. ¿ù°æ°ú´ÙÃâÇ÷(HMB)Àº °íÁÖÆÄ ¼ÒÀÛ ÀåÄ¡ÀÎ NovaSure·Î Ä¡·áÇÒ ¼ö ÀÖ½À´Ï´Ù.
Endometrial Ablation Market size was valued at US$ 398.6 Million in 2024, expanding at a CAGR of 5.80% from 2025 to 2032.
A non-invasive procedure known as "endometrial ablation" involves either destroying or ablation of the endometrium, which is the outermost layer of the uterus. One technique used to manage irregular uterine bleeding is endometrial ablation. Persistent irregular uterine bleeding can also result in anaemia and low blood count. Since endometrial ablation requires no incisions and is preferred by many who experience menstrual problems, it has grown in popularity over time. The global endometrial ablation market is expected to grow as a result of the increasing incidence of cervical cancer, the development of next-generation ablation techniques and technologies, and the growth in the number of hospitals and surgical centres using ablation treatments. On the other hand, market expansion is probably going to be constrained by healthcare cost-cutting measures and an unwelcoming regulatory environment. Furthermore, promising opportunities are anticipated to arise soon as the general public is more aware of the variety of ablation procedures available.
Endometrial Ablation Market- Market Dynamics
Rising cases of abnormal uterine bleeding (AUB)
Increasing rates of abnormal uterine bleeding (AUB) is the key driver of the global market for endometrial ablation. AUB is a group of illnesses that can seriously lower a woman's quality of life and are characterized by irregular or extremely heavy menstrual flow. This includes menorrhagia, which is particularly severe or prolonged bleeding; menometrorrhagia, which is excessive bleeding during and between periods; and metrorrhagia, which is bleeding between periods. A variety of factors could cause the rise in AUB cases. As healthcare systems advance and more diagnoses and treatments are available, one significant factor contributing to the rise in women seeking medical advice and becoming more knowledgeable about menstrual health issues is the greater awareness and identification of menstrual difficulties. Among the lifestyle changes linked to increased incidences of AUB are increased stress, obesity, and changes in reproductive health behaviours.
Additionally, the ageing population is a significant cause of the increasing prevalence of AUB. The frequency of irregular menstruation is increased in older women due to hormonal abnormalities. This suggests that the number of women displaying symptoms of AUB is increasing, which increases the demand for effective treatments.
Endometrial Ablation Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2025-2032)
Based on type segmentation, the devices were predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Endometrial Ablation Market is segmented on the basis of Type, End Use, and Region.
On the basis of type, the market is segregated into Devices (Microwave energy, Radiofrequency ablation, Thermal Balloon, Cryoablation, Hydrothermal ablation, Hysteroscopy) and Procedures. In 2024, the market was dominated by the devices category. The availability of a number of efficient methods and tools, such as balloon therapy, which involves injecting heated fluid inside a balloon to shatter the endometrium; radiofrequency ablation, which uses high-energy radio waves to destroy the endometrial tissue; and the freezing and smashing of abnormal tissues using an extremely cold fluid or a device called a cryoprobe. Furthermore, the segment demand is largely attributable to advantages including efficacy, product ease, quicker treatment, and affordability when compared to additional endometrial removal equipment. Additionally, doctors' simple access to endometrial removal equipment is catalyzing the market segment's growth in the near future.
Based on end use, the market is divided into Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), and Others. In 2024, the hospitals category held a dominant market share. This importance is related to the increasing number of people who are hospitalized for gynaecological illnesses, which is fueled by hospitals' skilled care and advantageous reimbursement practices. Hospitals have cutting-edge treatment technology, which contributes to this segment's growth. In addition, the thorough handling of possible complications during surgical procedures and the availability of a variety of treatment options on hospital grounds help to increase patient volume in comparison to alternative healthcare environments.
Endometrial Ablation Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Endometrial Ablation. The region's supremacy is fueled by the rising prevalence of gynaecological problems, notable improvements in healthcare infrastructure, and the existence of important industrial companies that can supply state-of-the-art endometrial ablation equipment. In the US, efforts to improve healthcare quality and lower costs have been driven by a steadfast focus on patient outcomes and safety. Significant healthcare spending in the region, which is more than in other parts of the world, adds to the market's upward trajectory.
Furthermore, in the upcoming years, Asia Pacific is anticipated to expand at the greatest CAGR in the endometrial ablation market. The market is expanding as a result of the rising incidence of menorrhagia due to inadequate cleanliness practices and the growing need for cutting-edge and sophisticated endometrial ablation devices. Additionally, the segment may see profitable chances in the years to come due to favourable government regulations, increased investment in the healthcare industry, expanding awareness of irregular uterine bleeding, and growing receptivity to minimally invasive therapies.
The market for endometrial ablation is very competitive, with a number of major firms vying for market share by providing creative and practical treatments for gynaecological conditions. To improve patient outcomes and increase their market share, these businesses concentrate on product and technology developments. Smith & Nephew Plc, Johnson & Johnson, Hologic, Olympus Corporation, The Cooper Companies, Inc., Karl Storz GmbH & Co. KG and others are some of the leading companies in the market. These businesses use tactics including partnerships, acquisitions, mergers, and collaborations to broaden their product lines and bolster their international footprints. For instance, in March 2023, the EnSeal Endometrial Ablation System, a novel endometrial ablation tool, was introduced by Olympus Corporation. A bipolar radiofrequency ablation tool called the EnSeal Endometrial Ablation System is intended to treat HMB.
Recent Development
February 2023: Hologic Inc.'s NovaSure V5 Global Endometrial Ablation (GEA) has been approved by regulators for use in the Canadian and European markets. The purpose of this innovative medicine is to treat abnormal uterine bleeding (AUB).
January 2023: The NovaSure, a novel endometrial ablation device, was introduced by Hologic. Heavy menstrual bleeding (HMB) can be treated with the NovaSure, a radiofrequency ablation machine.